穴位持续皮下输注胰岛素治疗2型糖尿病疗效观察

摘要

Objective To observe the difference between continuous subcutaneous insulin infusion (CSII) at acupoint and CSII at non-acupoint in treating type 2 diabetes, for providing a novel option in selecting the insulin injection site. Method Sixty-six subjects with type 2 diabetes were randomized into a treatment group of 32 cases and a control group of 34 cases. The treatment group was intervened by CSII at acupoint, while the control group was intervened by CSII at non-acupoint. The body mass index (BMI), fasting plasma glucose (FPG), 2 h-postprandial plasma glucose (P2hPG), bedtime blood sugar, glycated hemoglobin (HbA1c), consumption of insulin, and the score of diabetes symptom grading and quantification of the two groups were compared. Result The blood sugar level, insulin consumption, HbA1c level and symptom score declined significantly after treatment in both groups (P<0.05);the BMI and initial dosage of insulin in the treatment group dropped significantly after treatment in the treatment group (P<0.05); after treatment, the BMI, FPG level, initial dosage of insulin and symptom score in the treatment group were markedly lower than those in the control group (P<0.05); there were no significant differences between the treatment group and the control group in the P2 hBG level, bedtime glucose sugar level, HbA1c level, pre-prandial insulin dose and total effective rate (P>0.05). Conclusion CSII at acupoint and at non-acupoint both can effectively improve the disease condition of type 2 diabetes. The treatment group is superior to the control group in controlling BMI and FPG, reducing the initial level of insulin, and improving the symptoms, and the treatment group presents a higher total effective rate with the increase of treatment duration compared with the control group. It is indicated that insulin infusion at abdominal acupoint has a certain advantage in the treatment of type 2 diabetes.%目的 观察并比较穴位持续皮下输注胰岛素(CSII)与非经非穴持续皮下输注胰岛素治疗2型糖尿病的临床疗效差异,为胰岛素注射部位提供新的选择方案.方法 将66例2型糖尿病患者随机分为治疗组32例、对照组34例.治疗组采用穴位持续皮下输注胰岛素,对照组采用非经非穴持续皮下输注胰岛素;比较两组体质量指数(BMI)、空腹血糖(FPG)、三餐后2 h血糖(P2hBG)、睡前血糖、糖化血红蛋白(HbA1c)、胰岛素使用量以及糖尿病症状分级量化评分.结果 治疗后两组患者血糖水平、胰岛素餐前大剂量、HbA1c、症状评分与治疗前相比均明显下降,差异有统计学意义(P<0.05);治疗组BMI、胰岛素基础量较治疗前明显降低(P<0.05);治疗组BMI、FPG、胰岛素基础量、症状评分比对照组显著降低,差异有统计学意义(P<0.05);而P2hBG、睡前血糖、HbA1c、胰岛素餐前大剂量、总有效率与对照组相比,差异无统计学意义(P>0.05).结论 穴位和非经非穴持续皮下输注胰岛素均能有效改善2型糖尿病病情.治疗组在控制BMI、稳定FPG、减少胰岛素基础量、改善症状方面优于对照组,且随疗程进展治疗组的总有效率具有高于对照组的趋势,提示选取腹部穴位输注胰岛素对2型糖尿病具有一定的治疗优势.